{
  "uuid" : "",
  "id" : "Radiation_therapy_for_prostate_cancer.v0.0.1",
  "gdl_version" : "2.1",
  "concept" : "gt0001",
  "language" : {
    "original_language" : "ISO_639-1::en"
  },
  "description" : {
    "original_author" : {
      "name" : "Kevin Arjona",
      "email" : "kevin.arjona@cambio.se",
      "organisation" : "Cambio CDS",
      "date" : "2025-11-25"
    },
    "lifecycle_state" : "DRAFTED",
    "details" : {
      "en" : {
        "id" : "en",
        "purpose" : "To determine the recommended radiation therapy modality for prostate cancer patients.",
        "keywords" : [
          "radiotherapy",
          "fractionation",
          "dose",
          "gray",
          "Gy",
          "prostate",
          "cancer",
          "brachytherapy",
          "risk",
          "radiation"
        ],
        "use" : "Use to generate a recommendation based on the Swedish national care program for prostate cancer.",
        "misuse" : "Not to be used for patients with distant metastasis.",
        "copyright" : "© Cambio CDS"
      }
    },
    "other_details" : {
      "references" : "Widmark A, Klepp O, Solberg A, Damber JE, Angelsen A, Fransson P, Lund JA, Tasdemir I, Hoyer M, Wiklund F, Fosså SD; Scandinavian Prostate Cancer Group Study 7; Swedish Association for Urological Oncology 3. Endocrine treatment, with or without radiotherapy, in locally advanced prostate cancer (SPCG-7/SFUO-3): an open randomised phase III trial. Lancet. 2009 Jan 24;373(9660):301-8. doi: 10.1016/S0140-6736(08)61815-2. Epub 2008 Dec 16. Erratum in: Lancet. 2009 Apr 4;373(9670):1174. PMID: 19091394.\n\nMottet N, Peneau M, Mazeron JJ, Molinie V, Richaud P. Addition of radiotherapy to long-term androgen deprivation in locally advanced prostate cancer: an open randomised phase 3 trial. Eur Urol. 2012 Aug;62(2):213-9. doi: 10.1016/j.eururo.2012.03.053. Epub 2012 Apr 3. PMID: 22502942.\n\nDenham JW, Steigler A, Lamb DS, Joseph D, Turner S, Matthews J, Atkinson C, North J, Christie D, Spry NA, Tai KH, Wynne C, D'Este C. Short-term neoadjuvant androgen deprivation and radiotherapy for locally advanced prostate cancer: 10-year data from the TROG 96.01 randomised trial. Lancet Oncol. 2011 May;12(5):451-9. doi: 10.1016/S1470-2045(11)70063-8. PMID: 21440505.\n\nNationellt vårdprogram prostatacancer [Internet]. Regionala cancercentrum i samverkan; 2023 [cited 2025 Nov 24]. Available from: https://kunskapsbanken.cancercentrum.se/diagnoser/prostatacancer/vardprogram/primar-behandling-av-prostatacancer-utan-spridning/",
      "en" : "Recommended type of radiation therapy in relation to risk group and N-stage."
    }
  },
  "definition" : {
    "data_bindings" : {
      "gt0002" : {
        "id" : "gt0002",
        "model_id" : "openEHR-EHR-OBSERVATION.prostate_radiation_therapy_in_relation_to_risk_group.v0",
        "template_id" : "openEHR-EHR-OBSERVATION.prostate_radiation_therapy_in_relation_to_risk_group.v0",
        "type" : "INPUT",
        "elements" : {
          "gt0003" : {
            "id" : "gt0003",
            "path" : "/data[at0001]/events[at0002]/data[at0003]/items[at0006]",
            "data_type" : "DV_CODED_TEXT",
            "allowed_values" : [
              "local::at0007",
              "local::at0008",
              "local::at0009",
              "local::at0010",
              "local::at0011",
              "local::at0012",
              "local::at0013"
            ]
          },
          "gt0004" : {
            "id" : "gt0004",
            "path" : "/data[at0001]/events[at0002]/data[at0003]/items[at0014]",
            "data_type" : "DV_CODED_TEXT",
            "allowed_values" : [
              "local::at0015",
              "local::at0016",
              "local::at0017",
              "local::at0018",
              "local::at0019",
              "local::at0020",
              "local::at0021",
              "local::at0022"
            ]
          }
        }
      },
      "gt0005" : {
        "id" : "gt0005",
        "model_id" : "openEHR-EHR-EVALUATION.prostate_radiation_therapy_assessment.v0",
        "template_id" : "openEHR-EHR-EVALUATION.prostate_radiation_therapy_assessment.v0",
        "type" : "OUTPUT",
        "elements" : {
          "gt0006" : {
            "id" : "gt0006",
            "path" : "/data[at0003]/items[at0010]",
            "data_type" : "DV_CODED_TEXT"
          },
          "gt0007" : {
            "id" : "gt0007",
            "path" : "/data[at0003]/items[at0005]",
            "data_type" : "DV_CODED_TEXT"
          }
        }
      }
    },
    "pre_conditions" : [
      "$gt0003|Risk Category|!=null",
      "$gt0004|Regimen type|!=null"
    ],
    "default_actions" : [
      "$gt0007|Recommendation status|=local::at0007|Not recommended|"
    ],
    "rules" : {
      "gt0012" : {
        "id" : "gt0012",
        "priority" : 11,
        "when" : [
          "$gt0003|Risk Category|==local::at0010|High risk|||$gt0003|Risk Category|==local::at0011|Very high risk / N1|",
          "$gt0004|Regimen type|==local::at0015|External RT: Conventional fractionation|"
        ],
        "then" : [
          "$gt0006|Recommended dose and fractionation|=local::at0011|Primary RT: 2 Gy x 39 fx|",
          "$gt0007|Recommendation status|=local::at0009|Recommended + focal boost, if necessary|"
        ]
      },
      "gt0013" : {
        "id" : "gt0013",
        "priority" : 10,
        "when" : [
          "$gt0003|Risk Category|==local::at0013|Postoperative radiation therapy (salvage)|",
          "$gt0004|Regimen type|==local::at0015|External RT: Conventional fractionation|"
        ],
        "then" : [
          "$gt0006|Recommended dose and fractionation|=local::at0012|Postop RT: 2 Gy x 32 fx or 2 Gy x 35 fx|",
          "$gt0007|Recommendation status|=local::at0006|Recommended|"
        ]
      },
      "gt0008" : {
        "id" : "gt0008",
        "priority" : 9,
        "when" : [
          "$gt0003|Risk Category|==local::at0008|Favorable intermediate risk|||$gt0003|Risk Category|==local::at0009|Unfavorable intermediate risk|||$gt0003|Risk Category|==local::at0010|High risk|",
          "$gt0004|Regimen type|==local::at0016|External RT: Moderate hypofractionation|"
        ],
        "then" : [
          "$gt0006|Recommended dose and fractionation|=local::at0013|3 Gy x 20-22 fx|",
          "$gt0007|Recommendation status|=local::at0006|Recommended|"
        ]
      },
      "gt0011" : {
        "id" : "gt0011",
        "priority" : 8,
        "when" : [
          "$gt0003|Risk Category|==local::at0007|Low risk|",
          "$gt0004|Regimen type|==local::at0016|External RT: Moderate hypofractionation|"
        ],
        "then" : [
          "$gt0006|Recommended dose and fractionation|=local::at0013|3 Gy x 20-22 fx|",
          "$gt0007|Recommendation status|=local::at0008|Consider/Conditional|"
        ]
      },
      "gt0009" : {
        "id" : "gt0009",
        "priority" : 7,
        "when" : [
          "$gt0003|Risk Category|==local::at0008|Favorable intermediate risk|||$gt0003|Risk Category|==local::at0009|Unfavorable intermediate risk|||$gt0003|Risk Category|==local::at0010|High risk|",
          "$gt0004|Regimen type|==local::at0017|External RT: Ultrahypofractionation|"
        ],
        "then" : [
          "$gt0006|Recommended dose and fractionation|=local::at0014|6.1 Gy x 7 fx|",
          "$gt0007|Recommendation status|=local::at0006|Recommended|"
        ]
      },
      "gt0010" : {
        "id" : "gt0010",
        "priority" : 6,
        "when" : [
          "$gt0003|Risk Category|==local::at0007|Low risk|",
          "$gt0004|Regimen type|==local::at0017|External RT: Ultrahypofractionation|"
        ],
        "then" : [
          "$gt0006|Recommended dose and fractionation|=local::at0014|6.1 Gy x 7 fx|",
          "$gt0007|Recommendation status|=local::at0008|Consider/Conditional|"
        ]
      },
      "gt0014" : {
        "id" : "gt0014",
        "priority" : 5,
        "when" : [
          "$gt0003|Risk Category|==local::at0010|High risk|||$gt0003|Risk Category|==local::at0011|Very high risk / N1|",
          "$gt0004|Regimen type|==local::at0018|External RT + Brachytherapy Boost: HDR BT (Ir 192)|"
        ],
        "then" : [
          "$gt0006|Recommended dose and fractionation|=local::at0015|14-15 Gy x 1 fx or 10 Gy x 2 fx|",
          "$gt0007|Recommendation status|=local::at0006|Recommended|"
        ]
      },
      "gt0015" : {
        "id" : "gt0015",
        "priority" : 4,
        "when" : [
          "$gt0003|Risk Category|==local::at0008|Favorable intermediate risk|||$gt0003|Risk Category|==local::at0009|Unfavorable intermediate risk|",
          "$gt0004|Regimen type|==local::at0019|Brachytherapy Monotherapy: HDR BT (Ir 192)|"
        ],
        "then" : [
          "$gt0006|Recommended dose and fractionation|=local::at0016|13-14 Gy x 2 fx|",
          "$gt0007|Recommendation status|=local::at0006|Recommended|"
        ]
      },
      "gt0016" : {
        "id" : "gt0016",
        "priority" : 3,
        "when" : [
          "$gt0003|Risk Category|==local::at0010|High risk|||$gt0003|Risk Category|==local::at0011|Very high risk / N1|",
          "$gt0004|Regimen type|==local::at0020|Lymph node irradiation|"
        ],
        "then" : [
          "$gt0007|Recommendation status|=local::at0006|Recommended|"
        ]
      },
      "gt0017" : {
        "id" : "gt0017",
        "priority" : 2,
        "when" : [
          "$gt0003|Risk Category|==local::at0012|M1 (Low volume)|",
          "$gt0004|Regimen type|==local::at0021|Moderate hypofractionation M1|"
        ],
        "then" : [
          "$gt0006|Recommended dose and fractionation|=local::at0017|2,75 Gy x 20 . 3 Gy x 19-20|",
          "$gt0007|Recommendation status|=local::at0006|Recommended|"
        ]
      },
      "gt0018" : {
        "id" : "gt0018",
        "priority" : 1,
        "when" : [
          "$gt0003|Risk Category|==local::at0012|M1 (Low volume)|",
          "$gt0004|Regimen type|==local::at0022|Ultrahypofractionation M1|"
        ],
        "then" : [
          "$gt0006|Recommended dose and fractionation|=local::at0018|6-6,1 Gy x 6|",
          "$gt0007|Recommendation status|=local::at0006|Recommended|"
        ]
      }
    }
  },
  "ontology" : {
    "term_definitions" : {
      "en" : {
        "id" : "en",
        "terms" : {
          "gt0001" : {
            "id" : "gt0001",
            "text" : "Radiation therapy for prostate cancer ",
            "description" : "Recommended type of radiation therapy in relation to risk group and N-stage."
          },
          "gt0002" : {
            "id" : "gt0002",
            "text" : "openEHR-EHR-OBSERVATION.prostate_radiation_therapy_in_relation_to_risk_group.v0"
          },
          "gt0003" : {
            "id" : "gt0003",
            "text" : "Risk Category"
          },
          "gt0004" : {
            "id" : "gt0004",
            "text" : "Regimen type"
          },
          "gt0005" : {
            "id" : "gt0005",
            "text" : "openEHR-EHR-EVALUATION.prostate_radiation_therapy_assessment.v0"
          },
          "gt0006" : {
            "id" : "gt0006",
            "text" : "Recommended dose and fractionation"
          },
          "gt0007" : {
            "id" : "gt0007",
            "text" : "Recommendation status"
          },
          "gt0008" : {
            "id" : "gt0008",
            "text" : "Set to External RT: Moderate hypofractionation 3 Gy x 20-22 fx",
            "description" : ""
          },
          "gt0009" : {
            "id" : "gt0009",
            "text" : "Set to External RT: Ultrahypofractionation 6.1 Gy x 7 fx",
            "description" : ""
          },
          "gt0010" : {
            "id" : "gt0010",
            "text" : "Set to External RT: Ultrahypofractionation 6.1 Gy x 7 fx conditional",
            "description" : ""
          },
          "gt0011" : {
            "id" : "gt0011",
            "text" : "Set to External RT: Moderate hypofractionation 3 Gy x 20-22 fx conditional",
            "description" : ""
          },
          "gt0012" : {
            "id" : "gt0012",
            "text" : "Set to External RT: Conventional fractionation. Primary RT: 2Gy x 39 fx",
            "description" : ""
          },
          "gt0013" : {
            "id" : "gt0013",
            "text" : "Set to External RT: Conventional fractionation. Postop RT: 2Gy x 32 fx or 2Gy x 35 fx",
            "description" : ""
          },
          "gt0014" : {
            "id" : "gt0014",
            "text" : "Set to External RT + Brachytherapy. 14-15 Gy x 1 fx or 10 Gy x 2 fx",
            "description" : ""
          },
          "gt0015" : {
            "id" : "gt0015",
            "text" : " Set to Brachytherapy monotherapy. 13-14 Gy x 2 fx",
            "description" : ""
          },
          "gt0016" : {
            "id" : "gt0016",
            "text" : "Set to Limph node irradiation recommended",
            "description" : ""
          },
          "gt0017" : {
            "id" : "gt0017",
            "text" : "Set to M1: 2,75 Gy x 20 fx or 3 Gy x 19-20 fx",
            "description" : ""
          },
          "gt0018" : {
            "id" : "gt0018",
            "text" : "Set to M1: 6-6.1 Gy x 6 fx",
            "description" : ""
          }
        }
      }
    }
  }
}